leadf
logo-loader
viewAnteris Technologies Ltd

Admedus enters trading halt ahead of capital raising

The capital raising could potentially be a placement, rights issue or share purchase plan.

highway sign saying 'funding next exit'
The company exceeded expectations with $6.2 million revenue for the March quarter

Admedus Ltd (ASX:AHZ) has been granted a trading halt by the ASX pending the release of further details regarding a capital raising.

Shares in the company will remain halted until further information is released or the commencement of trading on Thursday, whichever occurs earlier.

READ: Admedus has healthy mix of reliable Infusion earnings and strong revenue growth from ADAPT

Quick facts: Anteris Technologies Ltd

Price: 3.99 AUD

ASX:AVR
Market: ASX
Market Cap: $23.58 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Anteris Technologies Ltd named herein, including the promotion by the Company of Anteris Technologies Ltd in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Admedus CEO in New York to update on recent key milestones

Admedus Ltd (ASX:AHZ) CEO Wayne Paterson visited the Proactive Investors New York studio to update on key milestones the company has achieved in the past few months, including receiving European approval on two of its products.

on 03/17/2019

2 min read